Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
1,743
Views
9
CrossRef citations to date
0
Altmetric
Back Matter

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

Alessio Cortellinia Medical Oncology, St. Salvatore Hospital, L’Aquila, Italy;b Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1209-5735View further author information
ORCID Icon,
Sebastiano Butic Medical Oncology, University Hospital of Parma, Parma, ItalyORCID Iconhttps://orcid.org/0000-0003-0876-0226View further author information
ORCID Icon,
Melissa Bersanellic Medical Oncology, University Hospital of Parma, Parma, Italy;d Department of Medicine and Surgery, University of Parma, Parma, ItalyView further author information
,
Raffaele Giustie U.O.C. Oncologia Medica, Azienda Ospedaliero Universitaria Sant’Andrea, Rome, ItalyView further author information
,
Fabiana Perronec Medical Oncology, University Hospital of Parma, Parma, ItalyView further author information
,
Pietro Di Marinof Clinical Oncology Unit, S.S. Annunziata Hospital, Chieti, ItalyView further author information
,
Nicola Tinarig Department of Medical, Oral & Biotechnological Sciences, University G. D’Annunzio, Chieti-Pescara, ItalyView further author information
,
Michele De Tursig Department of Medical, Oral & Biotechnological Sciences, University G. D’Annunzio, Chieti-Pescara, ItalyView further author information
,
Antonino Grassadoniag Department of Medical, Oral & Biotechnological Sciences, University G. D’Annunzio, Chieti-Pescara, ItalyView further author information
,
Katia Cannitaa Medical Oncology, St. Salvatore Hospital, L’Aquila, ItalyView further author information
,
Alessandra Tessitoreb Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyView further author information
,
Federica Zorattoh Medical Oncology, Santa Maria Goretti Hospital, Latina, ItalyView further author information
,
Enzo Veltrih Medical Oncology, Santa Maria Goretti Hospital, Latina, ItalyView further author information
,
Francesco Malorgioi Medical Oncology, “Santo Spirito” Hospital, Pescara, ItalyView further author information
,
Marco Russanoj Medical Oncology, Campus Bio-Medico University, Rome, ItalyView further author information
,
Cecilia Anesij Medical Oncology, Campus Bio-Medico University, Rome, ItalyView further author information
,
Tea Zeppolaj Medical Oncology, Campus Bio-Medico University, Rome, ItalyView further author information
,
Marco Filettie U.O.C. Oncologia Medica, Azienda Ospedaliero Universitaria Sant’Andrea, Rome, ItalyView further author information
,
Paolo Marchettie U.O.C. Oncologia Medica, Azienda Ospedaliero Universitaria Sant’Andrea, Rome, Italy;k Medical Oncology, Sapienza University of Rome, Rome, Italy;l Medical Oncology (B), Policlinico Umberto I, Rome, Italy;m Medical Oncology, IDI-IRCCS, Roma, ItalyView further author information
,
Andrea Botticellik Medical Oncology, Sapienza University of Rome, Rome, ItalyView further author information
,
Gian Carlo Antonini Cappellinim Medical Oncology, IDI-IRCCS, Roma, ItalyView further author information
,
Federica De Galitiism Medical Oncology, IDI-IRCCS, Roma, ItalyView further author information
,
Maria Giuseppa Vitalen Medical Oncology, University Hospital of Modena, Modena, ItalyView further author information
,
Francesca Rastellio Medical Oncology, Fermo Area Vasta 4, Fermo, ItalyView further author information
,
Federica Pergolesio Medical Oncology, Fermo Area Vasta 4, Fermo, ItalyView further author information
,
Rossana Berardip Oncology Clinic, Università Politecnica delle Marche, Ancona, ItalyView further author information
,
Silvia Rinaldip Oncology Clinic, Università Politecnica delle Marche, Ancona, ItalyView further author information
,
Marianna Tudiniq Medical Oncology, AV2 Fabriano ASUR Marche, ItalyView further author information
,
Rosa Rita Silvaq Medical Oncology, AV2 Fabriano ASUR Marche, ItalyView further author information
,
Annagrazia Pireddur Medical Oncology Unit, University Hospital of Cagliari, Cagliari, ItalyView further author information
,
Francesco Atzorir Medical Oncology Unit, University Hospital of Cagliari, Cagliari, ItalyView further author information
,
Daniela Iaconos Pulmonary Oncology Unit, St. Camillo Forlanini Hospital, Rome, ItalyView further author information
,
Maria Rita Migliorinos Pulmonary Oncology Unit, St. Camillo Forlanini Hospital, Rome, ItalyView further author information
,
Alain Gelibterl Medical Oncology (B), Policlinico Umberto I, Rome, ItalyView further author information
,
Mario Alberto Occhipintil Medical Oncology (B), Policlinico Umberto I, Rome, ItalyView further author information
,
Francesco Martellat Medical Oncology, “G. Mazzini” Hospital, Teramo, ItalyView further author information
,
Alessandro Innou Medical Oncology Unit, IRCCS, Sacro Cuore Don Calabria Hospital, Verona, ItalyView further author information
,
Stefania Goriu Medical Oncology Unit, IRCCS, Sacro Cuore Don Calabria Hospital, Verona, ItalyView further author information
,
Sergio Bracardav Medical Oncology, Azienda Ospedaliera S. Maria, Terni, ItalyView further author information
,
Cristina Zannoriv Medical Oncology, Azienda Ospedaliera S. Maria, Terni, ItalyView further author information
,
Claudia Mosillov Medical Oncology, Azienda Ospedaliera S. Maria, Terni, ItalyView further author information
,
Alessandro Parisia Medical Oncology, St. Salvatore Hospital, L’Aquila, Italy;b Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyView further author information
,
Giampiero Porzioa Medical Oncology, St. Salvatore Hospital, L’Aquila, Italy;b Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyView further author information
,
Domenico Mallardow Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione “G. Pascale”, Naples, ItalyView further author information
,
Maria Concetta Fargnolib Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy;x Dermatology, San Salvatore Hospital, L’Aquila, ItalyView further author information
,
Marcello Tiseoc Medical Oncology, University Hospital of Parma, Parma, Italy;d Department of Medicine and Surgery, University of Parma, Parma, ItalyView further author information
,
Daniele Santinij Medical Oncology, Campus Bio-Medico University, Rome, ItalyView further author information
,
Paolo A Asciertow Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione “G. Pascale”, Naples, ItalyORCID Iconhttps://orcid.org/0000-0002-8322-475XView further author information
ORCID Icon &
Corrado Ficorellaa Medical Oncology, St. Salvatore Hospital, L’Aquila, Italy;b Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyView further author information
 show all
Article: 1710389 | Received 05 Oct 2019, Accepted 02 Dec 2019, Published online: 07 Jan 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.